S Immo AG
XMUN:T1L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
S Immo AG
XMUN:T1L
|
AT |
|
M
|
MindBio Therapeutics Corp
F:WF60
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is T1L's stock price target?
Not Available
T1L does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for S Immo AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for S Immo AG?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 22%.